कृपया अन्य खोज का प्रयास करें
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Richard J. Hawkins | 72 | 2007 | Independent Chairman of the Board |
Robert P. Lenk | 73 | 2020 | Independent Director |
Vladimir P. Torchilin | 74 | 2020 | Member of Scientific Advisory Board |
John C. McKew | 57 | 2020 | Member of Scientific Advisory Board |
Andrew J. Brenner | - | 2020 | Member of Scientific Advisory Board |
Marc H. Hedrick | 58 | 2002 | President, CEO & Director |
An van Es-Johansson | 61 | 2020 | Independent Director |
Howard Clowes | 67 | 2020 | Independent Director |
Michael Vogelbaum | - | 2020 | Member of Clinical Advisory Board |
Gregory B. Petersen | 58 | 2020 | Independent Director |
Nicholas Butowski | - | 2020 | Member of Clinical Advisory Board |
Manish Aghi | - | 2020 | Member of Clinical Advisory Board |
Alireza Mohammadi | - | 2020 | Member of Clinical Advisory Board |
Russell Lonser | - | 2020 | Member of Clinical Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है